Patients with trauma and lupus report significantly higher stress, but resilience and support may offer a buffer, with each additional positive factor linked to a 0.67 drop in perceived stress.
The psychiatric safety of semaglutide 2.4 mg for weight management in adults with overweight or obesity was evaluated in a recent analysis, which found no increased risk of depression or suicidal thoughts, emphasizing the importance of mental health monitoring for patients undergoing weight management treatment.
A recent trial suggests potential cognitive health benefits and reductions in brain age from following a green-Mediterranean diet rich in polyphenols, particularly for individuals with diabetes.
In this 68-week trial, semaglutide not only achieved 13.7% weight reduction but also decreased NSAID use and improved walking distance by 42.6 meters compared to placebo in patients with knee osteoarthritis, suggesting potential benefits beyond weight loss.
In a cohort study of 250 children, those exposed to cannabis prenatally (32%) showed 0.4 standard deviations lower scores in attention/inhibitory control and exhibited 17% more aggressive behaviors during laboratory assessments, despite no differences in caregiver-reported outcomes.
Despite being used in 42% of acute hospital admissions, urinary dipstick tests led to potentially unnecessary antibiotic treatment, with a 4.4-fold increased risk of empirical antibiotics in patients without UTI symptoms, according to a study of over 2,400 patients.
New research published in JAMA Pediatrics uncovers the impact of parenting behaviors during childhood on adolescent brain development and subsequent mental health in early adulthood.